Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Exchange Traded Product
-
Shares outstanding
-
778,318
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
704,202
-
Shares change
-
+107,742
-
Total reported value, excl. options
-
$21,394,229
-
Value change
-
+$3,273,617
-
Number of buys
-
13
-
Number of sells
-
-12
-
Price
-
$30.38
Significant Holders of FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product (XIDE) as of Q3 2025
29 filings reported holding XIDE - FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product as of Q3 2025.
FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product (XIDE) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 704,202 shares
of 778,318 outstanding shares and own 90.48% of the company stock.
Largest 10 shareholders include Sequent Planning LLC (82,753 shares), STEPHENS INC /AR/ (81,684 shares), Advisory Resource Group (71,517 shares), HARBOUR INVESTMENTS, INC. (60,940 shares), Triad Wealth Partners, LLC (57,853 shares), Foundations Investment Advisors, LLC (51,369 shares), Accel Wealth Management (40,226 shares), Kestra Advisory Services, LLC (34,178 shares), Cetera Investment Advisers (31,495 shares), and Mariner, LLC (24,493 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.